跳至主要内容
临床试验/NCT05665790
NCT05665790尚未招募不适用

Study on Primary Lesion Treatment for Patients With Bone Metastases

Shanghai 6th People's Hospital0 个研究点目标入组 400 人开始时间: 2023年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
400
主要终点
Disease control rate at 1 year

研究概览

简要总结

This study will carry out a prospective cohort study to study the effect of different primary leison treatment modes on disease control, quality of life, economic cost and survival period of patients with bone metastases from breast cancer and lung cancer by giving radiotherapy or palliative surgery or not giving local treatment for the primary lesion in patients with bone metastases from breast cancer or lung cancer

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HR positive breast cancer patients with bone metastasis or Non-small-cell lung cancer patients with bone metastasis;
  • Aged over 18;
  • Patients who benefit clinically(CR+PR) after 6 months of treatment.

排除标准

  • The expected life span is less than 3 months;
  • Have serious cardiovascular and cerebrovascular diseases, blood coagulation dysfunction, and cannot tolerate surgery;
  • Allergies to narcotic drugs;
  • The patient refused the treatment decision of the integrated team.

结局指标

主要结局

Disease control rate at 1 year

时间窗: 1 year

Disease control rate

次要结局

  • Progression-Free Survival(1 year)
  • Overall Survival(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhao Hui

Principal Investigator

Shanghai 6th People's Hospital

相似试验